Literature DB >> 6695860

The effect of media and temperature on the storage of Chlamydia trachomatis.

S L Aarnaes, E M Peterson, L M De La Maza.   

Abstract

Four media, Eagle's minimal essential medium with 10% fetal bovine serum (MEM/FBS), tryptic soy broth (TSB), 2-SP, and 4-SP, were compared for their ability to maintain the viability of Chlamydia trachomatis at 4 degrees C, -20 degrees C, -70 degrees C, and -176 degrees C (liquid nitrogen) over a 1-week period. 2-SP maintained viability of C. trachomatis to the greatest extent for all of the time intervals and temperatures examined. Therefore, in an attempt to further stabilize the viability of C. trachomatis, 2-SP was supplemented with various concentrations of bovine serum albumin (BSA) or fetal bovine serum (FBS). For the times and temperatures examined, 2-SP supplemented with 20% or 40% FBS or 5% BSA preserved infectivity to a greater extent than unsupplemented 2-SP. In some supplemented media, up to 65% of the infectivity was preserved after one week of storage at -176 degrees C, whereas only 0-3% of infectivity remained when stored in unsupplemented media at -20 degrees C and 4 degrees C, respectively. Therefore, supplementation of 2-SP with FBS or BSA can prolong the survival of chlamydia, which is critical in the transportation and storage of clinical specimens. In addition, storage for prolonged periods of time should be at -70 degrees C or lower temperatures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6695860     DOI: 10.1093/ajcp/81.2.237

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Evaluation of the rapid CLEARVIEW Chlamydia test for direct detection of chlamydiae from cervical specimens.

Authors:  N J Stratton; L Hirsch; F Harris; L M de la Maza; E M Peterson
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

2.  Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women.

Authors:  K A Crotchfelt; B Pare; C Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Evaluation of the digene hybrid capture II CT-ID test for detection of Chlamydia trachomatis in endocervical specimens.

Authors:  J L Girdner; A P Cullen; T G Salama; L He; A Lorincz; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Reproducibility problems with the AMPLICOR PCR Chlamydia trachomatis test.

Authors:  E M Peterson; V Darrow; J Blanding; S Aarnaes; L M de la Maza
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Molecular techniques for the detection of Chlamydia trachomatis.

Authors:  E M Peterson; R Oda; R Alexander; J R Greenwood; L M de la Maza
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

6.  Comparison of the Clearview Chlamydia, the PACE 2 assay, and culture for detection of Chlamydia trachomatis from cervical specimens in a low-prevalence population.

Authors:  J Blanding; L Hirsch; N Stranton; T Wright; S Aarnaes; L de la Maza; E M Peterson
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

7.  Evaluation of five immunoassays for detection of Chlamydia psittaci in cloacal and conjunctival specimens from turkeys.

Authors:  D Vanrompay; A Van Nerom; R Ducatelle; F Haesebrouck
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

8.  Chlamydia trachomatis infection in a high-risk population: comparison of polymerase chain reaction and cell culture for diagnosis and follow-up.

Authors:  W H Vogels; P C van Voorst Vader; F P Schröder
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

9.  Performance of a commercial polymerase chain reaction test for endocervical Chlamydia trachomatis infection in a university hospital population.

Authors:  C H Livengood; K A Boggess; J W Wrenn; A P Murtha
Journal:  Infect Dis Obstet Gynecol       Date:  1998
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.